IP Library Granted Patent US 6,962,970
Granted Patent B2
US 6,962,970 · App. 10/092,088 · Granted Nov 8, 2005

Glycopeptide derivatives and pharmaceutical compositions containing the same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,962,970
App. No.
10/092,088
Granted
Nov 8, 2005
Kind
B2
Abstract

Disclosed are derivatives of glycopeptide compounds having at least one substituent of the formula: —R a —Y—R b —(Z) x where R a , R b , Y, Z and x are as defined, and pharmaceutical compositions containing such glycopeptide derivatives. The disclosed glycopeptide derivatives are useful as antibacterial agents.

Claims (17)

1. A compound of formula II:

wherein

R 16 is hydrogen or methyl;

R 26 is hydrogen or methyl;

R 27 is hydrogen or —CH 2 COOH;

R a is —CH 2 CH 2 —, —CH 2 CH 2 CH 2 — or —CH 2 CH 2 CH 2 CH 2 —;

R b is alkylene having from 8 to 12 carbon atoms;

and pharmaceutically acceptable salts, stereoisomers and prodrugs thereof.

2. The compound of claim 1 , wherein R 16 is methyl.

3. The compound of claim 1 , wherein R 26 is methyl.

4. The compound of claim 1 , wherein R 27 is hydrogen.

5. The compound of claim 1 , wherein R a is —CH 2 CH 2 —.

6. The compound of claim 1 , wherein —R b —H is an n-octyl, n-nonyl, n-decyl, n-undecyl or n-dodecyl group.

7. The compound of claim 1 , wherein —R b —H is an n-decyl group.

8. The compound of claim 1 , wherein R 15 is —CH 2 CH 2 —NH—(CH 2 ) 10 —H.

9. A pharmaceutical composition comprising a compound of any of claims 1 - 8 and a pharmaceutically acceptable carrier.

10. A method of inhibiting the growth of bacteria in a mammal infected with or exposed to bacteria, the method comprising administering to the mammal a composition according to claim 9 for a time and under conditions effective to inhibit growth of bacteria.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 14, 2018
From: THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC
To: CUMBERLAND PHARMACEUTICALS INC.
Reel/Frame 047909/0853 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 11, 2014
From: THERAVANCE, INC.
To: THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC
Reel/Frame 033163/0031 →